These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Reasons for truly negative cytology reports preceding the diagnoses of invasive cervical cancer-Results of a false-negative cytology audit in Polish Cervical Cancer Screening Programme. Macios A, Komerska K, Nowakowski A. Cancer Med; 2023 Jun; 12(12):13800-13810. PubMed ID: 37211978 [Abstract] [Full Text] [Related]
7. A Groundbreaking Work Which Laid the Foundation for Mass Screening in Cervical Cytology in Japan. Osamura RY. Acta Cytol; 2017 Jun; 61(4-5):299-304. PubMed ID: 28693014 [Abstract] [Full Text] [Related]
8. Pap tests in the diagnosis of cervical cancer: Help or hinder? Philp L, Jembere N, Wang L, Gao J, Maguire B, Kupets R. Gynecol Oncol; 2018 Jul; 150(1):61-66. PubMed ID: 29773301 [Abstract] [Full Text] [Related]
9. High-grade cervical abnormalities and screening intervals in New South Wales, Australia. Schindeler S, Morrell S, Zuo Y, Baker D. J Med Screen; 2008 Jul; 15(1):36-43. PubMed ID: 18416954 [Abstract] [Full Text] [Related]
10. Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000-2011. Whop LJ, Baade P, Garvey G, Cunningham J, Brotherton JM, Lokuge K, Valery PC, O'Connell DL, Canfell K, Diaz A, Roder D, Gertig DM, Moore SP, Condon JR. PLoS One; 2016 Jul; 11(4):e0150473. PubMed ID: 27064273 [Abstract] [Full Text] [Related]
11. Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening study. Longatto-Filho A, Maeda MY, Erzen M, Branca M, Roteli-Martins C, Naud P, Derchain SF, Hammes L, Matos J, Gontijo R, Sarian LO, Lima TP, Tatti S, Syrjänen S, Syrjänen K. Acta Cytol; 2005 Jul; 49(5):500-6. PubMed ID: 16334026 [Abstract] [Full Text] [Related]
14. Factors related to inter-observer reproducibility of conventional Pap smear cytology: a multilevel analysis of smear and laboratory characteristics. Baena A, Guevara E, Almonte M, Arias-Stella J, Sasieni P, Sanchez GI. Cytopathology; 2017 Jun; 28(3):192-202. PubMed ID: 28029192 [Abstract] [Full Text] [Related]
16. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma. Li Z, Austin RM, Guo M, Zhao C. Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617 [Abstract] [Full Text] [Related]
18. Short interval between two Pap smears: effect on the result of the second smear? A prospective randomized trial. Kolben TM, Bergauer F, Moeckel J, Boettcher B, Thaler CJ, Kolben T, Crispin A, Dannecker C, Mahner S, Gallwas J. Arch Gynecol Obstet; 2017 Jun; 295(6):1427-1433. PubMed ID: 28405743 [Abstract] [Full Text] [Related]
19. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden. Wang J, Andrae B, Sundström K, Ploner A, Ström P, Elfström KM, Dillner J, Sparén P. PLoS Med; 2017 Oct; 14(10):e1002414. PubMed ID: 29065127 [Abstract] [Full Text] [Related]